DoW Peer Reviewed Medical, Clinical Trial Award
Defense Health Agency Contracting Activity - DHACA
Want a reminder before this closes?
We'll email you 3 days before the deadline. One email, then we stop.
Free. Verify your email, then we send one reminder only.
- Posted
- May 8, 2026
- Amount
- Program total $94.5M
- Closes
- Sep 22, 2026
Similar opportunities open now
- DoW Peer Reviewed Cancer, Clinical Trial AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses Oct 5, 2026
- DoW Peer Reviewed Medical, Platform Clinical Translation AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses Sep 22, 2026
- DoW, Peer Reviewed Cancer, Impact AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses Oct 5, 2026
- DoW Orthopaedic, Clinical Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses Nov 18, 2026 (in 57 days)
- DoW Peer Reviewed Cancer, Idea AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses Oct 5, 2026
Classification and identifiers
- Solicitation number
- HT942526PRMRPCTA
- Assistance listing (CFDA)
- 12.420
Amount
Program total $94.5M
Who can apply
About this opportunity
Summary: The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have significant impact on the treatment and management of a disease or condition addressed in one of the congressionally directed FY26 PRMRP topic areas and FY26 PRMRP strategic goals. Distinctive Features: Must support a clinical trial. Supports two different application categories, based on the phase of planning for the clinical trial: Clinical Trial Only or Clinical Trial with Planning Phase. The Clinical Trial with Planning Phase option is intended to support the final phase of regulatory activities and planning activities that are necessary to be completed prior to initiation of the clinical trial. The plan...